CoChat
Sign Up
Cited by 12Endometriosis Research and TreatmentEndometrial and Cervical Cancer TreatmentsMetastasis and carcinoma case studies

Outcome of a multimodal therapy of a recurrent adenocarcinoma arising from Caesarean section scar endometriosis—A case report

Open access
Drukała, Zbigniew, Ciborowska-Zielińska, Beata, Kubrak, Jadwiga, Rogowska, Danuta·2010·Reports of Practical Oncology & Radiotherapy
DOI 10.1016/j.rpor.2010.03.002PMC PMC3863218
Open this paper in CoChat — free account

Abstract

BACKGROUND: Endometriosis occurring in surgical scars is a well-described entity. Malignant transformation of endometriosis is a rare event, with most cases belonging to adenocarcinoma. The initial surgical treatment is a method of choice. Due to lack of therapeutic recommendations, adjuvant therapy and recurrence management are a great challenge for oncologists. AIM: The aim of this paper was to present a long-term survival as the outcome of multimodal therapy in the patient with recurrent adenocarcinoma arising from Caesarean section scar endometriosis. CASE: We present the case of a woman with recurrent adenocarcinoma arising from Caesarean section scar endometriosis. The disease was first diagnosed in September 1997 at age 43. The patient underwent abdominal hysterectomy with tumour excision. Due to a local recurrence after 4 years, tumour excision with abdominal wall repair using a plastic mesh, regional lymphadenectomy, bilateral salpingo-ovariectomy and adjuvant radiotherapy for the pelvic region with local boost were performed; in addition hormontherapy with medroxyprogesterone was started. Because of a recurrent pelvic tumour, chemotherapy, further local palliative radiotherapy and brachytherapy were administered. Subsequently distant metastases in bilateral axillary lymph nodes were diagnosed and palliative radiotherapy was performed. The patient died of morbus neoplasmaticus generalisatus in September 2008. The follow-up period had been 132 months. CONCLUSION: This paper is, to our knowledge, the only report in literature that presents a long-term survival as the outcome of multimodal therapy in the patient with this rare diagnosis. Further reports of new cases can help establish optimal treatment guidelines.

Integrity signals

Registry

Crossref · 10.1016/j.rpor.2010.03.002

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm.

    “Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm [63,64,65,66,67,68,69,70,71,72,73,74].”

    From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [70]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Drukała, Z., Ciborowska-Zielińska, B., Kubrak, J., & Rogowska, D.
Affiliations
Pomeranian Medical University (PL)
Corresponding author
Drukała, Zbigniew
Venue
Reports of Practical Oncology & Radiotherapy
Publisher
VM Media SP. zo.o VM Group SK
Published
2010-05
Volume
15
Issue
3
Pages
75-77
ISSN
  • 1428-2267 (ISSN-L)
  • 1507-1367
DOI
10.1016/j.rpor.2010.03.002
PMC
PMC3863218
OpenAlex
W2000593855
Cited by
12
References
21
Citations by year
2025: 2 · 2024: 1 · 2021: 3 · 2017: 3 · 2016: 2 · 2015: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Reports of Practical Oncology & Radiotherapy (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Metastasis and carcinoma case studies
Keywords
malignant transformation of endometriosis, multimodal therapy, adjuvant radiotherapy, brachytherapy, medroxyprogesterone, chemotherapy, axillary lymph node metastasis, long-term survival, abdominal hysterectomy, tumour excision

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review